Introduction
============

In recent years there has been growing interest in tonometric estimation of gastric pHi. More recently attention has focused on the gradient between intraluminal and arterial PCO~2~. pHi appears to be a useful diagnostic and prognostic tool in critically ill patients, and may also be used as a therapeutic guide \[[@B2],[@B3]\]. However, intraluminal PCO~2~ is the parameter measured to calculate pHi, and it is assumed as equivalent to the PCO~2~ of the upper layers of the gastric mucosa \[[@B4]\].

Direct measurement of PCO~2~ in gastric juice might offer additional advantages over tonometry. First, tonometer costs could be saved. Second, equilibration time would no longer be necessary. Finally, preanalytic factors that account for poor tonometric reproducibility, such as inadequate volume of saline in the tonometer, errors in timing the dwell time of the sample or in the technique used to aspirate the tonometered saline sample, mixing the sample with air from the tonometer dead space, and delays in specimen analysis, might be prevented \[[@B5]\].

Nevertheless, to our knowledge, very few studies, either experimental or clinical, have examined PCO~2~ in gastric juice \[[@B1],[@B6],[@B7]\]. Moreover, no comparison with tonometric samples obtained at the same time has been done. Our goal was to compare PCO~2~ obtained simultaneously in gastric juice and in saline samples from tonometers. The results of the present study show that gastric juice PCO~2~ is systematically higher, and that for high PCO~2~ values this difference widens and data dispersion is even more marked. Therefore, tonometric PCO~2~ and gastric juice PCO~2~ are not interchangeable.

Patients and methods
====================

The present study was approved by the local ethics committee and informed consent was obtained from the next of kin of each patient.

We consecutively studied 15 mechanically ventilated patients from a medical/surgical intensive care unit, in whom tonometric monitoring was indicated by attending physicians. All patients were receiving 50 mg intravenous ranitidine every 8 h. Gastric tonometers were filled with saline and, after 90 min for equilibration, saline samples were collected, as has previously been described \[[@B2]\]. At the same time, gastric juice was anaerobically extracted from the aspiration port of the tonometer. Initial 20 ml were discarded. A blood gas analyzer (AVL 945) was used to measure PCO~2~ in both samples. These measurements were taken at various time points in each patient, and under various haemodynamic and oxygen transport conditions. All measurements were performed with the patient fasted. Correlation between both of measurements was examined using the Bland-Altman technique \[[@B8]\].

We also performed an *in vitro* study to quantify the precision and bias of the AVL 945. For this purpose, a stable PCO~2~ in saline solution was achieved by bubbling 5% carbon dioxide calibration gas. Bias (mean difference from expected PCO~2~) and precision (standard deviation of the bias) of PCO~2~ measured in saline was determined by comparison of measured PCO~2~ with expected PCO~2~. The latter was calculated from the carbon dioxide content of the calibration gas and from barometric pressure, according to gas laws. Measurements were repeated six times.

Results
=======

We performed 112 pairs of measurements in 15 patients. Table [1](#T1){ref-type="table"} shows clinical data and the first values of arterial, tonometer and gastric juice PCO~2~ taken in each patient. Regression analysis demonstrated a significant correlation between both methods of measuring PCO~2~(*r*^2^ =0.43; gastric juice PCO~2~ = -28.79+ \[2.55 × tonometric PCO~2~\]; *P* \< 0.0001; Fig. [1](#F1){ref-type="fig"}). However, bias, calculated as the mean difference between gastric juice and tonometric PCO~2~, was 51 mmHg. The 95% limits of agreement were 315 mmHg (Fig. [2](#F2){ref-type="fig"}). When mean PCO~2~ values were less than 100 mmHg, bias and 95% limits of agreement were 19 and 102 mmHg, respectively. The scattering of differences widened as PCO~2~ increased (*r*^2^ =0.71; *P* \< 0.0001).

The two types of measurements are clearly correlated. However, they cannot be considered as interchangeable, because gastric juice PCO~2~ was always higher and the 95% limits of agreement were clinically significant.

In an effort to prevent bias related to multiple measurements per patient we used another approach, taking into account the initial measurement of each patient. Despite this, results continued to be similar (bias 55 mmHg, 95% limits of agreement 216 mmHg).

The AVL 945 blood gas analyzer showed a negative bias of 0.97 mmHg and a precision of 2.13 mmHg. This was considered negligible, so no further correction was done to tonometric values.

Discussion
==========

The present data show that tonometric PCO~2~ and gastric juice PCO~2~ should not be considered interchangeable,because gastric juice PCO~2~ was systematically higher. With high PCO~2~ values, this difference widened, and data dispersion became even more marked.

There is no clear cause for these observations. It can be argued that tonometric PCO~2~ is a value that is measured over a predetermined period, whereas gastric juice PCO~2~ may generate data on minute-to-minute changes in mucosal metabolism. This different equilibrium time could account for data dispersion. However, the positive bias for gastric juice is harder to interpret, because such rapid changes should appear in both directions.

Another potential confounding factor is the ability of blood gas analyzers to measure PCO~2~ in gastric juice. Measurement of PCO~2~ in saline is an important source of error in the estimation of pHi. The error lies both in the kind of blood gas analyzer used and in the PCO~2~ value itself \[[@B9],[@B10]\]. Different solutions might modify PCO~2~ measurement. For example, bias is -66.5% when the Nova Stat Profile 7 blood gas analyzer measures concentration of 1.95% of CO~2~ equilibrated in normal saline. However, bias changes to +45.4% when 1.95% CO~2~ is equilibrated in human albumin solution 4.5% \[[@B9]\].

It would not be surprising if different gastric juice buffers, such as proteins, mucopolisaccharides and others, interfere with CO~2~ solubility and its subsequent measurement. In this way, intersubject and intrasubject variation of gastric juice composition could also account for data dispersion. Therefore, analytic issues related to the various constituents of gastric juice could have added to the observed differences.

Fiddian-Green *et al* \[[@B1]\] measured PCO~2~ in gastric content of anaesthetised dogs. They isolated the stomach from the oesophagus and the duodenum with ligatures, and washed it through a catheter with saline. Then they instilled 250 ml saline and intermittently took samples to measure PCO~2~ and estimate pHi, which was compared with simultaneous direct mucosa pHi measurement performed using a microglass probe. They found a statistically significant correlation between both methods, but there was considerable data dispersion in the graph. However, in that study, as well as in others in which PCO~2~ was measured without a tonometer \[[@B6],[@B7]\], some kind of saline lavage was used. On the other hand, we directly measured PCO~2~ in gastric juice, which could produce marked differences in the results.

Differences between tonometric PCO~2~ and gastric juice PCO~2~ could be due to blood gas analyzers that are calibrated for blood gas analysis, and could systematically underestimate PCO~2~ in saline \[[@B9],[@B10]\]. Nevertheless, this explanation is not supported by the present *in vitro* results. The performance of the AVL 945 was fairly good. It showed a minor negative bias of less than 1 mmHg and a precision of approximately 2 mmHg. Thus, it appears to be a suitable device for saline tonometry.

We ascribe the high PCO~2~ values obtained in the present study to shock and subsequent gut hypoperfusion, as can be deduced from the clinical characteristics of our patients. Also, in the presence of hydrochloric acid, duodenal or gastric bicarbonate buffering could produce important amounts of carbon dioxide \[[@B11]\]. Although we cannot exclude spurious generation of carbon dioxide, measurements were performed in the fasted state, the position of the tonometer was checked by X-ray, and ranitidine was administered in each patient. If PCO~2~ in gastric juice and in the tonometer were interchangeable, their values would be similar, regardless of CO~2~ source or absolute value. However, gastric juice PCO~2~ and tonometric PCO~2~ were quite different. We believe that this is the novel point in this study.

Gastric juice PCO~2~ has been used in some clinical studies \[[@B6],[@B7],[@B12]\]. Mohsenifar *et al* \[[@B12]\] advocated its advantages over tonometry. However, the present results suggest that the two techniques are not interchangeable. From the present data we cannot infer which should be the gold standard technique for measurement of gastric mucosa PCO~2~. Nevertheless, knowledge regarding pHi has evolved from gastric tonometry; studies regarding normal values, prognostic changes and its uses as a therapeutic guide were performed using tonometry. Hence, until more and clearer data are reported, PCO~2~ measurement in gastric juice should be considered with caution.
